Pre-mRNA Processing Factor 31 (PRPF31) (Middle Region) Peptide
Quick Overview for Pre-mRNA Processing Factor 31 (PRPF31) (Middle Region) Peptide (ABIN8108843)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- PRPF31 Peptide - middle region
-
Sequence
- VKQVKPLPAP LDGQRKKRGG RRYRKMKERL GLTEIRKQAN RMSFGEIEED
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- PRPF31 Antibody (ARP87583_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PRPF31 (Pre-mRNA Processing Factor 31 (PRPF31))
-
Background
-
Background Information: This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.
Alternative Symbols: RP11, PRP31, SNRNP61, NY-BR-99
-
Molecular Weight
- 30 kDa
-
Gene ID
- 26121
-
NCBI Accession
- NP_056444
-
UniProt
- Q8WWY3
Target
-